^
CANCER:
Gastrointestinal Stromal Tumor
KIT positive
GIST
imatinib
Sensitive
:
A1
PDGFRA D842V
GIST
avapritinib
Sensitive
:
A1
No biomarker
GIST
sunitinib
Sensitive
:
A1
No biomarker
GIST
ripretinib
Sensitive
:
A1
PDGFRA exon 18 mutation
GIST
avapritinib
Sensitive
:
A1
No biomarker
GIST
regorafenib
Sensitive
:
A1
KIT expression
GIST
imatinib
Sensitive
:
A1
NTRK2 fusion
GIST
entrectinib
Sensitive
:
A2
NTRK1 fusion
GIST
entrectinib
Sensitive
:
A2
NTRK3 fusion
GIST
entrectinib
Sensitive
:
A2
NTRK3 fusion
GIST
larotrectinib
Sensitive
:
A2
NTRK2 fusion
GIST
larotrectinib
Sensitive
:
A2
NTRK1 fusion
GIST
larotrectinib
Sensitive
:
A2
No biomarker
GIST
cabozantinib tablet
Sensitive
:
A2
PDGFRA exon 18 mutation
GIST
imatinib
Sensitive
:
A2
No biomarker
GIST
imatinib
Sensitive
:
A2
PDGFRA D842V
GIST
dasatinib
Sensitive
:
A2
No biomarker
GIST
sorafenib
Sensitive
:
A2
No biomarker
GIST
pazopanib
Sensitive
:
A2
No biomarker
GIST
nilotinib
Sensitive
:
A2
KIT mutation
GIST
ripretinib
Sensitive
:
B
PDGFRA mutation
GIST
ripretinib
Sensitive
:
B
PDGFRA mutation
GIST
avapritinib
Sensitive
:
C2
PDGFRA mutation
GIST
imatinib
Sensitive
:
C2
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our